B 1ymphocytes are the central component of the humoral immune response and malignant B lymphocytes represent the primary cell type in leukemia and lymphoma Although B cells are activated and regulated through their cell- surface molecules, little is known about the structure and signal transduction pathways of most B cell-surface proteins other than immunoglobulin (Ig), Several B lymphocyte-restricted and -associated cell surface molecules have been identified that may serve critical roles in B lymphocyte function and adhesion with other cell types.
The aim of this project is to further examine the structure of several B cell surface molecules, CD19, CD20 and CD22 to determine their roles in B cell function. The first specific aim is to examine the structure, expression and function of the recently characterized CD19 signal-transducing complex present on B cells. CDI9 associates with a series-of other surface molecules to generate a functional signal generating.complex that includes CD21, TAPA-1, Leu-13 and additional uncharacterized proteins. The additional components of the complex will be identified and the structural requirements for complex formation will be determined. In addition, transgenic mice that express human CD19 have been generated that give rise to an abnormal phenotype. These mice will be used to characterize the struCture and function of both the human and mouse CD19 molecules and to further elucidate the mechanism of CD19 signal generation. CD19-deficient mice will also be produce by targeted disruption of the endogenous CD19 gene to further characterize the in vivo function of CD19. The second specific aim is to further examine the function of the B cell-specific CD20 molecule that regulates transmembrane Ca++ movement during B, lymphocyte cell cycle progression. CD20-deficient mice will also be produced by targeted disruption of thee endogenous CD20 gene. Mice that overexpress the human CD20 molecule on their 13 cells will also be produced to dissect the functional significance of CD20 in vivo and to determine what effect this has on normal Ca++ homeostasis and growth of B cells. The third specific aim is to further characterize the molecular basis for B cell adhesion through CD22. CD22 serves as a significant adhesion molecule for B lymphocytes that may also be important in cellular activation. In these studies, the receptor for CD22 will be identified-and it will be determined whether engagement of CD22 by this receptor has a functional effect on B cells. The roles of these proteins in B cell activation, proliferation, and differentiation will be examined. Determining the structural and functional characteristics of B cell- restricted proteins will provide a better understanding of how B cell function is regulated at the cell surface and may provide new methods for treatment of B cell malignancies and dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026872-07
Application #
2063594
Study Section
Experimental Immunology Study Section (EI)
Project Start
1988-07-01
Project End
1998-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Duke University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Yan, Z Q; Bolognesi, M P; Steeber, D A et al. (2000) Blockade of L-selectin attenuates reperfusion injury in a rat model. J Reconstr Microsurg 16:227-33
Nagaoka, T; Kaburagi, Y; Hamaguchi, Y et al. (2000) Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 157:237-47
Tu, L; Delahunty, M D; Ding, H et al. (1999) The cutaneous lymphocyte antigen is an essential component of the L-selectin ligand induced on human vascular endothelial cells. J Exp Med 189:241-52
Steeber, D A; Tang, M L; Green, N E et al. (1999) Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. J Immunol 163:2176-86
Tuscano, J M; Riva, A; Toscano, S N et al. (1999) CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade. Blood 94:1382-92
Li, X; Tedder, T F (1999) CHST1 and CHST2 sulfotransferases expressed by human vascular endothelial cells: cDNA cloning, expression, and chromosomal localization. Genomics 55:345-7
Sato, S; Tuscano, J M; Inaoki, M et al. (1998) CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. Semin Immunol 10:287-97
Steeber, D A; Tang, M L; Zhang, X Q et al. (1998) Efficient lymphocyte migration across high endothelial venules of mouse Peyer's patches requires overlapping expression of L-selectin and beta7 integrin. J Immunol 161:6638-47
Steeber, D A; Campbell, M A; Basit, A et al. (1998) Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc Natl Acad Sci U S A 95:7562-7
Twist, C J; Beier, D R; Disteche, C M et al. (1998) The mouse Cd83 gene: structure, domain organization, and chromosome localization. Immunogenetics 48:383-93

Showing the most recent 10 out of 84 publications